My research has focused on development of PET probes for imaging receptors, enzymes and transporters in diabetes and the other disease. Development PET radiotracers for imaging pancreatic islet cells (beta cells): Islet transplantation may prevent or even reverse T1D complications, as well as improve quality of life through a reduction or elimination of hypoglycemia and/or hypoglycemia unawareness. Despite its great therapeutic potential, however, to date, 80-90% of patients have experienced loss of transplanted islets within 5 years of transplantation, necessitating a return to insulin use. The ability to monitor transplanted islets would be instrumental to improving long-term transplantation outcomes. However, due to the lack of available tools to monitor islets post-transplant, estimates of their survival and function are limited to indirect assessments. Such assessments, which are based on changes in patient insulin requirements or metabolism, may be influenced and rendered inaccurate by fluctuations in the metabolic state and insulin secretory capacity of beta cells under various physiologic and pathophysiologic conditions. The goal of this research is to develop a non-invasive PET methodology for quantitatively monitoring transplanted islets. We evaluate the ability of our candidate PET probes to track transplanted islets in rodents and non-human primates, while continuing to develop a robust library of probes and validate them in animal models.
start-up rewards
The Larry L. Hillblom Foundation
Senior Scientist or Principal Investigator
city of hope
01 Dec 2014 - present